Off-market insider buying at Canadian International Pharma (T:CIP)

Douglas Lawrence Mason, CEO and 10% Holder, acquired 100,000 Common Shares at a price of $0.050 and 100,000 Warrants exercisable at $0.10 for a period of one year on a direct ownership basis through a private transaction on July 28th, 2017. Under the same terms, Mr. Mason also acquired 900,000 Common Shares and 900,000 Warrants for registered holder Criterion Capital Corporation through a private transaction on July 28th, 2017. This represents a $50,000 investment into the company's shares and an account share holdings change of greater than 100%.

Under the same terms, Mehrun Payravi, a 10% Holder, acquired 1,000,000 Common Shares and 1,000,000 Warrants on a control or direction basis for registered holder RRSP at an exercise price of $0.100 through a private transaction on July 28th, 2017. This represents a $50,000 investment into the company's shares and an account share holdings change of 50.0%.